Provectus Biopharmaceuticals (NYSE:PVCT)- Active Broker's Choice in Focus: Agilent Technologies (NYSE:A)
Provectus Biopharmaceuticals, Inc. (NYSE:PVCT) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with 14.81% to $0.02. Provectus Biopharmaceuticals, Inc. (PVCT) announced that it has commenced a rights offering, pursuant to which the Company is issuing subscription rights to purchase units to (i) the Company’s existing common stockholders and to (ii) holders of the Company’s class of warrants with an exercise price of $0.85 per share expiring June 19, 2020. Holders will receive one subscription right for each 20 shares of common stock an...